Fulvira 250 mg Injection
138,36$
113,33$
Fulvira 250 mg Injection is a targeted anticancer therapy specifically designed for the treatment of breast cancer in postmenopausal women. This medication is particularly effective for those with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer who have previously undergone endocrine therapy. When used in combination with palbociclib, Fulvira helps to enhance treatment outcomes by significantly reducing estrogen levels, which in turn slows the proliferation of cancer cells. It is essential to discuss potential side effects and contraindications with a healthcare provider, as Fulvira may not be suitable for everyone and can interact with other medications. Patients should be monitored closely for any adverse reactions during treatment. By targeting the hormonal pathways involved in breast cancer progression, Fulvira offers a promising option for managing this challenging disease. Always consult with your oncologist to determine the most appropriate treatment plan tailored to your individual needs.
Quantité
Active Pharmaceutical Ingredient
Uses
• Fulvira 250 mg injection is primarily used in the treatment of hormone receptor-positive breast cancer. This medication helps inhibit the growth of cancer cells by blocking estrogen's effects, which can contribute to tumor development. Patients receiving Fulvira 250 mg injection may experience a reduction in symptoms related to breast cancer. These symptoms can include physical changes in the breast and discomfort in the surrounding areas.
• In addition to its role in managing symptoms, Fulvira 250 mg injection is often utilized in advanced breast cancer cases. It is particularly effective for patients who have previously undergone other forms of hormonal therapy. By providing a different mechanism of action, Fulvira 250 mg injection can help improve patient outcomes. This makes it a valuable option in the treatment landscape for advanced disease.
• Fulvira 250 mg injection is commonly administered as part of a comprehensive treatment plan for breast cancer. Healthcare providers may use it alongside other therapies to enhance overall effectiveness. The injection can help stabilize the disease, allowing patients to maintain a better quality of life. Regular administration of Fulvira 250 mg injection can be a key component in managing ongoing treatment goals.
• Patients who receive Fulvira 250 mg injection may also benefit from monitoring their response to the medication. This allows healthcare professionals to adjust treatment plans as necessary based on individual progress. Fulvira 250 mg injection contributes to a personalized approach to breast cancer management. Through this tailored treatment, patients can work towards achieving optimal results in their fight against cancer.
Benefits
Fulvira 250 mg effectively reduces the symptoms associated with breast cancer, such as breast lumps, bloody nipple discharge, or changes in the shape or texture of the breast. Its mechanism of action involves altering the production of hormones that are essential for the growth and metastasis of breast cancer cells. It may also interact with other hormones or directly inhibit cancer growth. It is essential to receive Fulvira Injection 250 mg by injection from a doctor or nurse as self-administration is not recommended.It is important to look at your doctor's instructions carefully.
Side Effects
As with all medicines, Fulvira 250 mg Injection may cause some side effects. If you experience any of these side effects, you should contact your doctor or health care professional as soon as possible. Your doctor may be able to suggest ways in which these side effects can be managed or the severity of them reduced.
Most Common Side Effects
• Back pain
• Diarrhoea
• Vaginal bleeding
• Muscle and Joint pain
• Reaction in the injection site
• Vomiting
• Nausea
• Numbness
• Appetite loss
• Sweating
• Infection in the urinary tract
Common Side Effects
• Blood clots
• Low platelets count
• Liver failure
• Swelling in tongue, mouth, throat, and face
How To Use
The Fulvira 250 mg Injection is administered by a healthcare professional or nurse in a hospital or clinic setting by intravenous infusion under the skin. The specific dosage and administration of Anti-cancer Fulvestrant Injection will be determined by the patient's clinical condition, age, medical history, and other factors. It is important to note that this Fulvestrant Injection should not be self-administered, and it is important to follow the instructions of the healthcare professional administering the Fulvestrant 250 mg/5 ml Prefilled Syringe.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Fulvira 250 mg. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Fulvestrant Injection should be used with caution in patients with kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Fulvestrant 250 mg/5 ml Prefilled Syringe and report any unusual symptoms or changes in kidney function to their doctor. The dose of Fulvestrant Injection may need to be adjusted in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Fulvira Injection 250 mg. Fulvira 250 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Fulvestrant Injection, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Fulvira Injection 250 mg should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Fulvestrant Injection and report any unusual symptoms or changes in liver function to their doctor. The dose of Fulvira Injection 250 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Fulvestrant 250 mg/5 ml Prefilled Syringe may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Fulvestrant Injection during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Fulvira 250 mg Injection is unlikely to affect your ability to drive or operate machinery. If you experience any side effects while taking Fulvira Injection 250 mg such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved.